Skip to main content
Military Medicine logoLink to Military Medicine
. 2025 Apr 3;190(11-12):e2273–e2277. doi: 10.1093/milmed/usaf100

Rapid Initiation of Hyperbaric Oxygen Therapy for Multiple Simultaneous Cases of Acute Carbon Monoxide Poisoning at a Single Center

Takayuki Kurokawa 1,2,✉,2, Ichiyo Ohara 3,2, Chie Watanabe 4,5,2, Koji Kuwata 6,7,2, Itsumi Hashimoto 8,9,2, Manabu Kitagaki 10,11,2, Takehiko Murakami 12,13,2
PMCID: PMC12588713  PMID: 40178904

ABSTRACT

Introduction

Hyperbaric oxygen therapy (HBOT) is used to treat acute carbon monoxide poisoning. However, few reports have detailed its use in large patient cohorts, and optimal management guidelines have yet to be established. Herein, we report the clinical presentation and simultaneous treatment of multiple patients experiencing acute carbon monoxide poisoning on an offshore ship within the territorial waters of Japan.

Case presentation

Eleven patients were promptly transported to our hospital from a Japanese Maritime Self-Defense Force destroyer owing to accidental acute carbon monoxide poisoning. We opted to treat this incident as a mass casualty and immediately appointed a medical control officer and established medical teams. The medical control officer guided the general treatment plan and coordinated with the various sections, and the medical teams treated the patients. The patients were immediately administered normobaric oxygen via a facial mask. Those with the most severe conditions underwent simultaneous HBOT within 3 hours of hospital arrival. Two and 4 weeks after the second therapy session, all symptoms had resolved, with no physical or cognitive sequelae.

Conclusion

We report the successful treatment of patients with concurrent acute carbon monoxide poisoning via HBOT at a single facility. This report highlights the feasibility of efficacious treatment at a single facility in scenarios in which multiple individuals experience carbon monoxide poisoning. It is important that all staff members, including those in administration, understand the concept of disaster medicine. Additionally, in HBOT facilities, regular training is needed for events involving a large number of HBOT-indicated patients.

INTRODUCTION

Carbon monoxide (CO) is generated by the incomplete combustion of organic matter. In confined spaces, CO accumulation can result in acute CO poisoning (ACOP). In accidental events, mass exposure of a large number of individuals to CO may occur simultaneously.1

Our 100-bed hospital is managed by the Japanese Maritime Self-Defense Force (JMSDF). It is equipped with 2 type-2 multiplace hyperbaric oxygen therapy (HBOT) chambers and actively performs HBOT. A similar type-2 HBOT facility near our hospital is managed by another JMSDF squadron.

In this report, we describe the simultaneous treatment of multiple patients afflicted with ACOP on an offshore ship within the territorial waters of Japan. Notably, initial HBOT was immediately administered, and no neurological sequelae were encountered.

CASE PRESENTATION

Ethical standards were applied in this human research study.

In September 2017, a civilian worker (patient A in Table 1) on a JMSDF destroyer experienced malaise and loss of consciousness while performing repairs inside a sewage tank with a running engine generator. His colleagues attempted to rescue him but subsequently experienced similar symptoms (Table 1). Although ventilation within the tank took place indoors, the exhaust gas from the generator was released outdoors through a duct.

Table 1.

Patient characteristics

Blood CO-Hb (%)
Pt Age (years),sex SDF/Civ LOC Symptoms Medical history Smoker Pre-HBOT Day 0 Day 1 HBOT protocol
A 65, M Civ Yes Numbness, fatigue, headache None Yes 41.5 2.0 0.8 TT6 × 3, TT5 × 2
B 73, M Civ No Eye field abnormality, headache None Yes 37.4 3.6 0.8 TT6 × 3, TT5 × 2
C 67, M Civ No None None Yes 36.1 2.7 0.9 TT6 × 3, TT5 × 2
D 40, M Civ No Numbness, fatigue Type 2 DM Yes 31.8 0.8 0.0 TT6 × 3, TT5 × 2
E 38, F Civ Yes Numbness, hyperventilation None Yes 18.6 0.8 0.5 TT6 × 3, TT5 × 2
F 49, M SDF No Dull headache None Yes 22.8 0.6 0.6 TT6 × 2, TT5 × 3
G 23, M SDF No Dull headache None Yes 15.8 0.5 0.5 TT6 × 1, TT5 × 2
H 29, M SDF No Dull headache None Yes 10.1 0.6 0.5 TT6 × 1, TT5 × 2
I 46, M SDF No Chills None Yes 8.7 0.8 0.7 TT6 × 1, TT5 × 2
J 46, M SDF No Dull headache None No 6.4 0.6 0.6 TT6 × 1, TT5 × 2
K 29, M SDF No Dull headache None Yes 3.9 0.3 0.3 TT6 × 1, TT5 × 2
L 27, M SDF No Headache, nausea None Yes 3.5 0.8 TT6 × 1, TT5 × 2
M 46, M SDF No Headache None Yes 2.8 0.5 TT6 × 2, TT5 × 1
N 39, M SDF No Headache None Yes 1.0 (Day 1) 0.4 TT5 × 3
O 47, M SDF No Eye field abnormality, headache None Yes 1.4 (Day 1) 0.9 TT5 × 3
P 51, M SDF No None None Yes 3.6 (Day 1) 1.1 TT5 × 3

Abbreviations: Pt, patient; M, male; F, female; SDF, Self-Defense Force personnel; Civ, civilian; LOC, loss of consciousness; HBOT, hyperbaric oxygen therapy; CO-Hb, carboxyhemoglobin; TT, treatment table; DM, diabetes mellitus.

Details of the timeline are presented in Table 2 and Figure 1. Initially, the information from the scene was confusing, and we struggled to organize a medical treatment system. However, once it became clear that at least 6 patients were involved, we opted to treat the CO exposure (and presumed ACOP) as a mass casualty. To manage the event without disrupting outpatient care, we appointed a medical control officer (MCO) and established 6 separate medical teams based in the emergency department. The MCO guided the general treatment plan and coordinated the various aspects of the plan, and the medical teams were responsible for treating the patients. The patients were triaged at the aid station on the pier, and 11 patients (A to K) were transported by ambulance to our hospital, located approximately 5 minutes away, in order of severity. Patients L and M were late-arrival walk-ins.

Table 2.

Timeline of the events (on the day of the accident)

Time Event Details
∼10:30 Accident occurred One patient with LOC on the destroyer
∼10:35 Emergency call Nearest JMSDF MSU team (EMT, nurses) arrived at the destroyer
∼10:40 Triage at the scene by the MSU team
10:45 First call “The accident in the destroyer may be due to ACOP.”
“Request to accept 4 patients obtained, one with LOC.”
10:48 Mass casualty declared Assigned an MCO, called for an HBOT team
11:00 Second call “Request to accept 1 conscious patient.”
11:15 Third call “Request to accept 6 patients. LOC patient recovered consciousness.”
Assigned 6 medical teams (MD, nurses)
11:24 Patient arrival Patients A and B, via ambulance
11:35 Patient arrival Patients C to F, via ambulance
11:40 ACOP diagnosed
HBOT control (first) The MCO approved the provision of HBOT.
11:45 Patient arrival Patients G to K, walk-in
12:50 HBOT set-up (first) Patients A to F transferred to our HBOT facility
13:00 HBOT control (second) The MCO began negotiating to another HBOT facility, and assembling a second HBOT team.
13:13 HBOT start (first) Protocol: Table 6 of the US Diving Manual 2
14:15 Patient arrival Patient L, by walk-in
14:20 HBOT set-up (second) Patients G to K, transferred to another HBOT facility
14:35 HBOT start (second) Protocol: Table 6 of the US Navy Diving Manual 2
16:45 Patient arrival Patient M, walk-in
18:10 HBOT finish (first) No problems
19:32 HBOT finish (second) No problems

Abbreviations: LOC, loss of consciousness; MOC, medical control officer; MSU, Medical Service Unit; EMT, emergency medical technician; HBOT, hyperbaric oxygen therapy; MD, medical doctor.

Figure 1.

Figure 1.

Time course of arrival to initial HBOT.

Patient characteristics are presented in Table 1. Upon arrival at our hospital, all patients were immediately administered normobaric oxygen via a facial mask. The results of the physical exams were unremarkable for all 16 patients, with no obvious injuries. Laboratory results, including pCO2 and pO2 levels, were within normal limits, except for carboxyhemoglobin (CO-Hb) levels, which were elevated in patients A to K.

We immediately divided the patients into 2 groups (most severe and less severe) and administered HBOT within 3 hours of the exposure to the most severely injured patients (A to F) and approximately 4 hours after the exposure to the less severely injured patients (G to K). The general conditions and vital signs of patients L and M were stable; therefore, normobaric oxygenation therapy was initially administered, and HBOT was performed the next day. The day following the accident, elevated CO-Hb levels or post-exposure symptoms despite normal CO-Hb levels were observed in outpatients N to P.

All 16 patients were diagnosed with ACOP and underwent ongoing normobaric oxygenation therapy and at least 3 HBOT sessions, as outlined in Treatment Tables (TT) 5 and 6 of the U.S. Navy Diving Manual, during hospitalization.2 Not all patients required myringotomy. Although symptoms resolved in all patients after the second HBOT session, 6 patients (A to F) underwent 5 sessions owing to elevated CO-Hb levels. All patients were discharged after completing their scheduled HBOT sessions and were followed up at 2 and 4 weeks after the exposure. As soon as possible after admission and at the 4-week follow-up, the patients underwent brain magnetic resonance imaging and cognitive function tests. No abnormalities were evident in any of the patients at either time.

DISCUSSION

We report the clinical presentation and treatment of a large number of patients with ACOP occurring at an offshore location. The treatment of ACOP primarily aims to prevent (1) acute organ hypoxia, especially in the brain and myocardium, by reducing CO-Hb levels during the acute phase and (2) late-onset brain damage and neuropsychiatric disorders.1 Despite controversy regarding the role of HBOT in ACOP,3–5 some studies suggest that HBOT reduces the risk of chronic cognitive impairment in patients with specific symptoms.6,7 In our cohort, several criteria for ACOP were met (Table 3), including impaired consciousness (patients A and E), CO-Hb of 25% or more (patients A to D), and age over 36 years (patients A to F, I, J, and M to P) (Table 3).1,7,8 Although patients G, H, K, and L did not meet these criteria, they were considered eligible for HBOT because they exhibited symptoms and worked in the same confined space as did the other patients.1

Table 3.

The reasons for HBOT indication

Pt.
Criteria A B C D E F G H I J K L M N O P
Impairment of consciousness Yes No No No Yes No No No No No No No No No No No
Initial CO-Hb > 25% Yes Yes Yes Yes No No No No No No No No No No No No
Age > 36 Yes Yes Yes Yes Yes Yes No No Yes Yes No No Yes Yes Yes Yes
Existing physical symptom Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No

Abbreviations: HBOT, hyperbaric oxygen therapy; Pt, patient; CO-Hb, carboxyhemoglobin.

In our study, treatment proceeded smoothly owing to the early admission of the large cohort and the appointment of an MCO to manage various adjustments. HBOT was planned, and all 16 patients received treatment as scheduled. Although a single HBOT session can last more than 4 hours,2 many patients can be treated simultaneously in a type-2 HBOT facility. Therefore, if the number of patients, their symptoms, and the facility’s treatment capacity and equipment performance are deemed acceptable, multiple patients can be treated simultaneously in a single facility.

We could find no consensus regarding the appropriate HBOT protocol for ACOP treatment; different protocols have been presented.1,4 Therefore, we performed the protocols listed in TT 5 and 6 of the U.S. Navy Diving Manual,2 which is frequently used at our facility. In TT 6, the patient is pressurized to 60 feet and administered oxygen for 60 minutes and then pressurized to 30 feet and administered oxygen for 120 minutes. The total treatment time is 4 hours and 45 minutes. In TT 5, the patient is pressurized to 60 feet and administered oxygen for 40 minutes and then pressurized to 30 feet and administered oxygen for 20 minutes. The total treatment time is 2 hours and 15 minutes.

We determined that patients A to F, who exhibited particularly high CO-Hb levels, should receive 5 HBOT sessions. Given their severe ACOP, we aimed to maximize oxygen administration through HBOT. However, we recognized that dispensing an excessive amount of oxygen increases the risk of oxygen toxicity. Therefore, we planned to provide an oxygen amount that would avoid this risk while still being effective. The protocol for doing so was determined under the supervision of an HBOT expert. There were no adverse effects of the treatment and no ACOP sequelae. However, the number of HBOT sessions and choice of protocol require continued discussion.

In a mass casualty event, patients should be dispersed to various facilities with appropriate treatment capabilities. Based on preliminary observations, including transient loss of consciousness in some patients, the cause of the symptoms in the present report was likely ACOP. Therefore, we determined that immediate HBOT was necessary, and 11 patients (A to K) were simultaneously admitted to our hospital. Notably, dispersing patients to more distant facilities would have required oxygenation during transport, numerous oxygen cylinders, and several ambulances, leading to a significant delay in HBOT initiation, as described by Valerio et al.9 In the present study, the time from ASOP onset to HBOT initiation was within 3 hours for patients A to F and approximately 4 hours for patients G to K (Table 2). Lee et al. reported that the neurocognitive prognosis is significantly worse when HBOT is initiated ≥6 vs. <6 hours after ACOP onset.10 Therefore, treating all patients at our facility was the best option, and treatment was successfully accomplished by dividing the patients into 2 severity-based groups.

Important for a successful treatment of ACOP by HBOT is a full understanding of the urgency of the situation by not only the medical staff but also receptionists, administrators, drivers, and procurers of medical equipment such as oxygen. Cooperation among these individuals and knowledge of disaster medicine by all, including the administrative staff, is essential. However, a different strategy may be required for larger exposure groups or even for the same exposure group, depending on the timing and clinical presentations. Specifically, if the number of patients exceeds the capacity of the HBOT facility, evacuation to and performance of HBOT at another facility should be considered in addition to treatment at the facility following triage. Therefore, when training HBOT personnel to handle a large number of patients, the possibility of ACOP among the patients should be taken into account.

CONCLUSION

We initiated HBOT almost simultaneously at a single facility despite a large number of patients with ACOP and obtained good outcomes. In cases where HBOT may be beneficial and the number of nearby facilities is limited, treatment at a single facility should be considered to prioritize early treatment initiation. Assigning an MCO for local disasters and focused coordination can ensure smoother operation and effective treatment. Importantly all staff members, including managers, should understand the concept of disaster medicine, and HBOT facilities should conduct regular training sessions for potential situations involving a large number of patients with ACOP.

ACKNOWLEDGMENTS

We thank the members of Undersea Medical Center, JMSDF, for supporting our treatment.

Contributor Information

CAPT Takayuki Kurokawa, Department of Clinical Service, Japan Self-Defense Forces Hospital Yokosuka, Yokosuka, Kanagawa 237-0071, Japan; Department of Defense Medicine, National Defense Medical College, Saitama 359-8513, Japan.

CAPT Ichiyo Ohara, Department of Clinical Service, Japan Self-Defense Forces Hospital Yokosuka, Yokosuka, Kanagawa 237-0071, Japan.

LCDR Chie Watanabe, Department of Clinical Service, Japan Self-Defense Forces Hospital Yokosuka, Yokosuka, Kanagawa 237-0071, Japan; Department of Internal Medicine, National Defense Medical College, Saitama 359-8513, Japan.

LCDR Koji Kuwata, Department of Clinical Service, Japan Self-Defense Forces Hospital Yokosuka, Yokosuka, Kanagawa 237-0071, Japan; Department of Internal Medicine, National Defense Medical College, Saitama 359-8513, Japan.

CDR Itsumi Hashimoto, Department of Clinical Service, Japan Self-Defense Forces Hospital Yokosuka, Yokosuka, Kanagawa 237-0071, Japan; Department of Preventive Medicine and Public Health, National Defense Medical College, Saitama 359-8513, Japan.

CAPT Manabu Kitagaki, Department of Clinical Service, Japan Self-Defense Forces Hospital Yokosuka, Yokosuka, Kanagawa 237-0071, Japan; Bureau of Personnel and Education, Japan Ministry of Defense, Shinjuku, Tokyo 162-8801, Japan.

VADM Takehiko Murakami, Department of Clinical Service, Japan Self-Defense Forces Hospital Yokosuka, Yokosuka, Kanagawa 237-0071, Japan; Medical Science Course, School of Clinical Sciences, Kanagawa Dental University, Yokosuka, Kanagawa 236-8580, Japan.

FUNDING

None declared.

CONFLICT OF INTEREST STATEMENT

None declared.

DATA AVAILABILITY

There are no new data associated with this article.

INSTITUTIONAL REVIEW BOARD

This report was not reviewed by the Institutional Review Board (IRB) of the Japan Self Defense Force Hospital Yokosuka. Written informed consent was obtained from all patients.

INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE

Not applicable.

INSTITUTIONAL CLEARANCE

Institutional clearance does not apply.

INDIVIDUAL AUTHOR CONTRIBUTION STATEMENT

T.K., I.O., C.W.-F., K.K., I.H., and M.K., treated the patients in this report. T.K. and T.M. controlled the situation. All authors assisted in formatting the manuscript with a literature review and manuscript completion. All authors read and approved the final manuscript.

CLINICAL TRIAL REGISTRATION

Not applicable.

REFERENCES

  • 1. Jain  KK. Carbon monoxide and other tissue poisons. In: Jain  KK, ed. Textbook of Hyperbaric Medicine. 6th ed. Springer; 2017:131–54 [Google Scholar]
  • 2. U.S. Navy . U.S. Navy Diving Manual Revision 7. 2016;SS521-AG-PRO-010. Updated December 2016. Accessed October 23, 2024.  https://www.navsea.navy.mil/Portals/103/Documents/SUPSALV/Diving/US%20DIVING%20MANUAL_REV7.pdf?ver=2017-01-11-102354-393
  • 3. Weaver  LK. Carbon Monoxide Poisoning. Undersea Hyperb Med. 2020;47(2):151–69.doi: 10.1016/S0749-0704(05)70056-7 [DOI] [PubMed] [Google Scholar]
  • 4. Rose  JJ, Wang  L, Xu  Q, et al.  Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy. Am J Respir Crit Care Med. 2017;195(5):596–606.doi: 10.1164/rccm.201606-1275CI [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Nañagas  KA, Penfound  SJ, Kao  LW. Carbon Monoxide Toxicity. Emerg Med Clin N Am. 2022;40(2):282–313. doi: 10.1016/j.emc.2022.01.005 [DOI] [PubMed] [Google Scholar]
  • 6. Weaver  LK, Hopkins  RO, Chan  KJ. Hyperbaric Oxygen for Acute Carbon Monoxide Poisoning. N Engl J Med. 2002;347(14):1057–67.doi: 10.1056/NEJMoa013121 [DOI] [PubMed] [Google Scholar]
  • 7. Thom  SR. Carbon monoxide pathophysiology and treatment. In: Neuman  TS, Thom  SR, eds. Physiology and Medicine of Hyperbaric Oxygen Therapy. Saunders; 2008:321–47 [Google Scholar]
  • 8. Weaver  LK, Valentine  KJ, Hopkins  RO. Carbon Monoxide Poisoning: Risk Factors for Cognitive Sequelae and the Role of Hyperbaric Oxygen. Am J Respir Crit Care Med. 2007;176(5):491–7.doi: 10.1164/rccm.200701-026OC [DOI] [PubMed] [Google Scholar]
  • 9. Valerio  A, Verzè  M, Marchiori  F, et al.  Managing a Mass CO Poisoning: Critical Issues and Solutions from the Field to the Hyperbaric Chamber. Disaster Med Public Health Prep. 2017;11(2):251–5.doi: 10.1017/dmp.2016.112 [DOI] [PubMed] [Google Scholar]
  • 10. Lee  Y, Cha  YS, Kim  SH, Kim  H. Effect of Hyperbaric Oxygen Therapy Initiation Time in Acute Carbon Monoxide Poisoning. Crit Care Med. 2021;49(10):e910–9.doi: 10.1097/CCM.0000000000005112 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

There are no new data associated with this article.


Articles from Military Medicine are provided here courtesy of Oxford University Press

RESOURCES